Long-term safety and effectiveness of ritonavir (RTV), nelfinavir (NFV) and lopinavir/ritonavir (LPWr) in antiretroviral (ARV)-experienced HIV-1-infected children

被引:0
|
作者
Rudin, Christoph
Burri, Marcus
Shen, Yang
Rode, Richard
Nadal, David
机构
[1] Univ Basel, Childrens Hosp, Basel, Switzerland
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Univ Zurich, Childrens Hosp, Div Infect Dis, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:13S / 13S
页数:1
相关论文
共 50 条
  • [31] Insulin resistance in HIV-infected patients receiving long-term therapy with efavirenz, lopinavir/ritonavir and atazanavir
    Bernal, Enrique
    Masia, Mar
    Padilla, Sergio
    Ramos, J. Manuel
    Martin-Hidalgo, Alberto
    Gutierrez, Felix
    MEDICINA CLINICA, 2007, 129 (07): : 252 - 254
  • [32] Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy
    Kline, Mark W.
    Rugina, Sorin
    Ilie, Margareta
    Matusa, Rodica F.
    Schweitzer, Ana-Maria
    Calles, Nancy R.
    Schwarzwald, Heidi L.
    PEDIATRICS, 2007, 119 (05) : E1116 - E1120
  • [33] Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1-infected Children and Adolescents in Rwanda
    Mutwa, Philippe R.
    Boer, Kimberly R.
    Rusine, John
    Muganga, Narcisse
    Tuyishimire, Diane
    Schuurman, Rob
    Reiss, Peter
    Lange, Joep M. A.
    Geelen, Sibyl P. M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (01) : 63 - 69
  • [34] Efficacy and Safety of Tipranavir Coadministered with Ritonavir in HIV-1-Infected Children and Adolescents: 5 Years of Experience
    Salazar, Juan C.
    Cahn, Pedro
    Della Negra, Marinella
    De Aquino, Maria Zilda
    Robinson, Patrick A.
    Jelaska, Ante
    Mikl, Jaromir
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (04) : 396 - 400
  • [35] Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
    Weerawat Manosuthi
    Supeda Thongyen
    Samruay Nilkamhang
    Sukanya Manosuthi
    Somnuek Sungkanuparph
    AIDS Research and Therapy, 9
  • [36] Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
    Manosuthi, Weerawat
    Thongyen, Supeda
    Nilkamhang, Samruay
    Manosuthi, Sukanya
    Sungkanuparph, Somnuek
    AIDS RESEARCH AND THERAPY, 2012, 9
  • [37] Cost of switching darunavir plus ritonavir (DRV plus RTV) to lopinavir/ritonavir (LPV/r) in HIV-1-infected treatment-na ve women of child-bearing age (WOCBA)
    Baran, R.
    Moller, J.
    Desai, K.
    Simpson, K.
    Van de Steen, O.
    Dietz, B.
    Gooch, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 67 - 67
  • [38] Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children
    Bergshoeff, AS
    Fraaij, PL
    Ndagijimana, J
    Verweel, G
    Hartwig, NG
    Niehues, T
    De Groot, R
    Burger, DM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (01) : 63 - 68
  • [39] Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
    Orrell, Catherine
    Felizarta, Franco
    Nell, Andre
    Kakuda, Thomas N.
    Lavreys, Ludo
    Nijs, Steven
    Tambuyzer, Lotke
    Van Solingen-Ristea, Rodica
    Tomaka, Frank L.
    AIDS RESEARCH AND TREATMENT, 2015, 2015
  • [40] Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients
    Burgos, Joaquin
    Crespo, Manuel
    Falco, Vicenc
    Curran, Adria
    Navarro, Jordi
    Imaz, Arkaitz
    Domingo, Pere
    Podzamczer, Daniel
    Gracia Mateo, Ma
    Villar, Sara
    Van den Eynde, Eva
    Ribera, Esteve
    Pahissa, Albert
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (10) : 2479 - 2486